Services

recombinant exosomes

We have developed a platform technology to engineer the CD81 extracellular loop domain on EVs to select binders to specific cell surface proteins. Proof of Principle has been successfully achieved for recombinant extracellular vesicles targeting laminin and EGFR specifically. This technology will allow the development of a broad range of new therapeutic applications and targeting strategies in the extracellular vesicle space.

Related Services

establishment of stable cell lines for proudction of extracellular vesicles

P-MSC/TERT308

Placental amnion-derived mesenchymal stem cells

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

Related Services

establishment of stable cell lines for proudction of extracellular vesicles

WJ-MSC/TERT273

Wharton´s Jelly derived mesenchymal stem cells

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

Related Products

adipose-derived mesenchymal stem cells ASC/TERT300 for production of extracellular vesicles

EV cell factory for production of clinical grade extracellular vesicles

Related Services

establishment of stable cell lines for production of extracellular vesicles / exosomes for clinical application

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.